Company intelligence / Profile preview

InnoMedicus

Cham, Zug, Switzerland

Ownership: Private
Employees: ~10
Development stage: Other

Overview

InnoMedicus is a Swiss medical technology company focused on precise diagnostics and minimally invasive therapies in urology, particularly prostate and bladder cancer care. The company supplies medical devices, consumables, software solutions, and related training and integration services to hospitals and urology centers across Europe. Its offering includes prostate fusion biopsy systems, HIFU-based focal therapy solutions, single-use endoscopy products, ultrasound systems, and workflow integration support. In November 2025, InnoMedicus was acquired by Asker Healthcare Group, and it continues to operate as an active company within the group.

Therapeutic areas: OncologyNephrology
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

Asker Healthcare GroupArtemisSonablateTerason

Beyond the preview

Go deeper on InnoMedicus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoMedicus.

Explore the full profile